drugset / Trial / NCT02260570

Remediation of Impaired Self-Regulation in Patients With Mild TBI

NCT02260570 ↗

RandomizedCrossoverDouble-blindBasic science

Summary

The ability to regulate impulses enables us to plan for the future, to maintain focus in the face of distractions (i.e. to encode memories), and to manage emotions. This self regulation can be compromised in individuals who have a history of mild traumatic brain injury and co-occurring disorders. In this study the investigators are using functional MRI scanning to understand how memory and self regulation are expressed in the brains of people with a history of mild traumatic brain injury. The investigators are also testing whether the medication tolcapone may improve memory and self regulation.

Timeline

Start
2015-08-01
Primary completion
2021-06-30
Completion
2021-06-30

Outcome

Met primary endpoint

registry analysis (superiority test); Tolcapone vs Placebo; p <0.0001; F value 24.1; ANOVA; note: This p-value is adjusted for multiple comparisons. NCT02260570 ↗

paper Subjects with more severe PTSD showed both greater tolcapone-mediated improvements in d' and larger tolcapone-mediated reductions in liberally-biased responding for fearful stimuli. PMID 34253715 ↗

registry analysis (superiority test); Tolcapone vs Placebo; p = 0.0184; F value 6.23; ANOVA; note: This p-value is adjusted for multiple comparisons. NCT02260570 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolcapone Unknown — —